• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Determination of binding conformations of drugs to HAS and modeling of drug-HAS complex

Research Project

Project/Area Number 12672095
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionKitasato University

Principal Investigator

HIRONO Shuichi  School of Pharm. Sci. Kitasato Univ. Professor, 薬学部, 教授 (30146328)

Co-Investigator(Kenkyū-buntansha) YAMAOTSU Noriyuki  School of Pharm. Sci. Kitasato Univ. Assistant, 薬学部, 助手 (60230322)
GOUDA Hiroaki  School of Pharm. Sci. Kitasato Univ. Assistant Prof., 薬学部, 講師 (60276160)
MATSUSHITA Yasuo  School of Pharm. Sci. Kitasato Univ. Assistant Prof., 薬学部, 講師 (40050653)
NAKAGOME Izumi  School of Pharm. Sci. Kitasato Univ. Assistant, 薬学部, 助手 (30237242)
Project Period (FY) 2000 – 2001
KeywordsMolecular Dynamics / SUPERPOSE / Human Serum Albumin / Binding Conformation / Site I / Site II / NMR / Docking
Research Abstract

(1) It was carried out about the TRNOE measurement, the conformational analysis of binding drug (CAMDAS method, SUPERPOSE method etc.), contraction of the complex model by Flexi Dock method and molecular dynamics (MD) simulation of the complex model in the water solution.
(2) Construction of complex models were carried out by docking (SYBYL Ver6.7: Tripos Co.) between binding conformations og drugs and HAS.
I) Site I complex models
It could think about drugs which did binding at site I with hydrogen bond or electrostatic interaction between the part of negative charges of drugs and LYS199, ARG222, ARG257. It is found that benzen ring and alkyl group of drug forms hydrophobic interactions with PHE211, TRP214, PHE223, LEU238, ILE264, LEU276 and LEU290.
II) Site II complex models
The electrostatic interactions between the part of negative charges and ARG410, TYR411 and ARG485 were suggested at the site II binding drugs. Furthermore, the part of hydrophobic of the drugs could think what fit did in hydrophobic pocket composed of VAL415, LEU423, LEU460 and PHE488 and so on.
(3) Molecular dynamics (MD) simulation of complex models
It was suggested that the interaction (hydrogen bond, electrostatic and hydrophobic) shown with (2)-I) and (2)-II) were influence even in the water solution as a results of carrying out MD simulation about the constructed complex models (BMT354-site I and TLM53-site II) in the water.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] H.Gouda et al.: "Three-Dimensional Structure-Activity relationship Analysis between Motilin and Motilide Using Confomatinal Analysisi and a Novel Molecular Superposing Method"Chem.Pharm.Bull.. 48. 1835-1837 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A.A.Radwan et al.: "Rational Procedure for 3D-QSAR Analysis using TRNOE Experiments and Computatinal Methods: Application to Thermolvsis Inhibitors"Drug Design and Discovery. 17. 265-281 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] N.Yamaotsu et al.: "Molecular dynanic Simulation of calmodulin-Trifluoperazine Complex in Aqueous Solution"Biopolymers. 58. 410-421 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H. Gouda et al.: "Three-Dimensional Structure-Activity relationship Analysis between Motilin and Motilide Using Conformational Analysis and a Novel Molecular Superposing Method"Chem. Pharm. Bull. 48(11). 1835-1837 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] A. A. Radwan et al.: "Rational Procedure for 3D-QSAR Analysis using TRNOE Experiments and Computatinal Methods: Application to Thermolysis Inhibitors"Drug Design and Discovery. 17. 265-281 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] N. Yamaotsu et al.: "Molecular Dynamic simulation of Calmodulin-Trifluoperazine Complex in Aqueous Solution"Biopolymers. 58. 410-421 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi